Cambridge Investment Research Advisors, Inc. Neuroone Medical Technologies Corp Transaction History
Cambridge Investment Research Advisors, Inc.
- $29.6 Billion
- Q1 2025
A detailed history of Cambridge Investment Research Advisors, Inc. transactions in Neuroone Medical Technologies Corp stock. As of the latest transaction made, Cambridge Investment Research Advisors, Inc. holds 81,000 shares of NMTC stock, worth $71,280. This represents 0.0% of its overall portfolio holdings.
Number of Shares
81,000Holding current value
$71,280% of portfolio
0.0%Shares
2 transactions
Others Institutions Holding NMTC
# of Institutions
21Shares Held
1.93MCall Options Held
69.6KPut Options Held
2K-
Vanguard Group Inc Valley Forge, PA1.11MShares$977,4070.0% of portfolio
-
Geode Capital Management, LLC Boston, MA346KShares$304,4580.0% of portfolio
-
Goldman Sachs Group Inc New York, NY98.6KShares$86,7440.0% of portfolio
-
State Street Corp Boston, MA59.5KShares$52,3590.0% of portfolio
-
Blair William & CO Chicago, IL55.6KShares$48,8890.0% of portfolio
About NEUROONE MEDICAL TECHNOLOGIES Corp
- Ticker NMTC
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 16,209,200
- Market Cap $14.3M
- Description
- NeuroOne Medical Technologies Corporation operates as a medical technology company. The company focuses on the development and commercialization of thin film electrode technology for continuous electroencephalogram (cEEG) and stereoelectroencephalography (sEEG) recording, spinal cord stimulation, brain stimulation, and ablation solutions for pat...